Definitive Healthcare Corp.

NasdaqGS:DH Stock Report

Market Cap: US$1.2b

Definitive Healthcare Future Growth

Future criteria checks 0/6

Definitive Healthcare is forecast to grow earnings and revenue by 120.8% and 7.2% per annum respectively. EPS is expected to grow by 115% per annum. Return on equity is forecast to be 8.7% in 3 years.

Key information

120.8%

Earnings growth rate

115.0%

EPS growth rate

Healthcare Services earnings growth27.5%
Revenue growth rate7.2%
Future return on equity8.7%
Analyst coverage

Good

Last updated12 Apr 2024

Recent future growth updates

Recent updates

Pinning Down Definitive Healthcare Corp.'s (NASDAQ:DH) P/S Is Difficult Right Now

Apr 14
Pinning Down Definitive Healthcare Corp.'s (NASDAQ:DH) P/S Is Difficult Right Now

Definitive Healthcare: Reiterate Buy Rating As I Expect Growth To Recover In FY25

Mar 19

Is Definitive Healthcare (NASDAQ:DH) Using Debt In A Risky Way?

Feb 16
Is Definitive Healthcare (NASDAQ:DH) Using Debt In A Risky Way?

An Intrinsic Calculation For Definitive Healthcare Corp. (NASDAQ:DH) Suggests It's 42% Undervalued

Dec 29
An Intrinsic Calculation For Definitive Healthcare Corp. (NASDAQ:DH) Suggests It's 42% Undervalued

Definitive Healthcare Corp. (NASDAQ:DH) Stock Rockets 31% As Investors Are Less Pessimistic Than Expected

Nov 24
Definitive Healthcare Corp. (NASDAQ:DH) Stock Rockets 31% As Investors Are Less Pessimistic Than Expected

Estimating The Fair Value Of Definitive Healthcare Corp. (NASDAQ:DH)

Jun 02
Estimating The Fair Value Of Definitive Healthcare Corp. (NASDAQ:DH)

Definitive Healthcare Corp. (NASDAQ:DH) First-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year

May 06
Definitive Healthcare Corp. (NASDAQ:DH) First-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year

A Look At The Fair Value Of Definitive Healthcare Corp. (NASDAQ:DH)

Dec 08
A Look At The Fair Value Of Definitive Healthcare Corp. (NASDAQ:DH)

Definitive Healthcare Grows Headcount Despite Gathering Recession Clouds

Aug 31

Definitive Healthcare Corp.'s (NASDAQ:DH) Intrinsic Value Is Potentially 27% Above Its Share Price

Jul 17
Definitive Healthcare Corp.'s (NASDAQ:DH) Intrinsic Value Is Potentially 27% Above Its Share Price

Definitive Healthcare: No Involvement Yet Here

Jun 05

Estimating The Fair Value Of Definitive Healthcare Corp. (NASDAQ:DH)

Apr 01
Estimating The Fair Value Of Definitive Healthcare Corp. (NASDAQ:DH)

Definitive Healthcare: Getting Healthier

Jan 20

A Look At The Intrinsic Value Of Definitive Healthcare Corp. (NASDAQ:DH)

Dec 15
A Look At The Intrinsic Value Of Definitive Healthcare Corp. (NASDAQ:DH)

Definitive Healthcare: Definitely Not For Me Here

Sep 24

Earnings and Revenue Growth Forecasts

NasdaqGS:DH - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/2026315N/A1061125
12/31/2025287-18869311
12/31/2024266-21677312
12/31/2023251-2023841N/A
9/30/2023246-1822532N/A
6/30/2023238-142533N/A
3/31/2023232-112837N/A
12/31/2022223-72736N/A
9/30/2022208-273944N/A
6/30/2022194-322932N/A
3/31/2022179-162225N/A
12/31/2021166-181825N/A
9/30/2021153-82430N/A
6/30/2021140N/A2631N/A
3/31/202112822530N/A
12/31/2020118N/A2223N/A
12/31/201986-362022N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: DH is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: DH is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: DH is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: DH's revenue (7.2% per year) is forecast to grow slower than the US market (8.1% per year).

High Growth Revenue: DH's revenue (7.2% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: DH's Return on Equity is forecast to be low in 3 years time (8.7%).


Discover growth companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.